Comparison of Pelvimetric Measurements Between MRI and Low-dose Stereoradiography (EOS® Imaging System)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

35 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-11-09

Study Completion Date

2023-07-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this study is to compare pelvimetric measurements performed by Magnetic Resonance Imaging (MRI) and by the EOS imaging system.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Performance Evaluation of System EOS Imaging in Pelvimetry Versus Pelvi-scanner

NCT02834897

Radiation Obstetric Labor Complications Pregnancy Complications

COMPLETED NA

EOS® Versus Spiral CT Technique for Achieving a Pelvimetry in Suites of Obstructed Labor.

NCT02675179

Pregnancy

COMPLETED NA

Comparison of the Non-invasive Approach and Fetal Exome Sequencing in Prenatal Diagnosis When Fetal Ultrasound Signs Are Discovered

NCT05182242

Antenatal Congenital Malformations

COMPLETED NA

Comparison of EXperts and IA-assisted Residents

NCT07133165

Obstetric Ultrasound Biometric Measurements With or Without IA

COMPLETED

The 3-Dimensional Ultrasound for Fetal Anomaly Scan

NCT00966537

Pregnancy

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

During pregnancy, after failure of External Manual Version (EMV) in case of breech fetal presentation, a radiological pelvimetry is performed to evaluate the measurements of the pelvis and decide on the appropriate mode of delivery.

Several imaging modalities are used, including pelvic computed tomography (CT),and magnetic resonance imaging (MRI) of the pelvis.

CT scan has the disadvantage of maternal irradiation and MRI has the disadvantage of an inaccurate morphological analysis.The EOS® system is an imaging tool used in radiopediatric to allow precise morphological analysis of bone masses with minimal irradiation.

The quality of the morphological analysis and measurements provided by the EOS® imaging system is the reason for proposing this study comparing the pelvimetric measurements obtained by MRI and by the EOS® imaging system.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breech Fetal Presentation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pelvimetry group

The participants oh this group will successively perform MRI pelvimetry and EOS imaging.

Group Type EXPERIMENTAL

Pelvimetric measurements

Intervention Type OTHER

The patients in this group are pregnant women after failure of external manual version (EMV) in case of breech fetal presentation. The participants will successively perform MRI pelvimetry (conventional management) and EOS imaging.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pelvimetric measurements

The patients in this group are pregnant women after failure of external manual version (EMV) in case of breech fetal presentation. The participants will successively perform MRI pelvimetry (conventional management) and EOS imaging.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients \> 18 years of age
* Patient requiring pelvimetry (breech fetus)
* Gestation \> 36 SA (weeks of amenorrhea)
* Patients with BMI \< 35
* Affiliated to social security or similarly regime
* Patients who gave their consent to participate in the study (Patient having agreed to perform both examinations: MRI and EOS system)

Exclusion Criteria

* Patient with a contraindication to MRI (claustrophobia, pace-maker, intracorporeal metallic element)
* Patient with a contraindication to performing EOS® (person not standing alone)
* Patient who are in exlusion period of another interventiionnal study
* Person deprived of freedom by judicial or administrative decision; person hospitalized for psychitric care; person under legal protection measure.

Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes